© 2001 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Enhanced protein phosphorylation in hypertensive hypertrophy
aInstitut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, Westfälische Wilhelms-Universität, Domagkstraße 12, D-48129 Münster, Germany
bInstitut für Pharmakologie und Toxikologie, Martin-Luther-Universität, Magdeburger Straße 4, D-06097 Halle, Germany
* Corresponding author. Tel.: +49-251-835-5517; fax: +49-251-835-5501 boknik{at}uni-muenster.de
Objective: Chronic pressure overload in spontaneously hypertensive rats (SHR) is accompanied by heart hypertrophy and signs of heart failure. Since there is growing evidence for a possible pathophysiological role of altered protein phosphorylation in heart hypertrophy and failure, we studied here cardiac regulatory phosphoproteins and the kinases and phosphatases which regulate their phosphorylation state. Methods: The experiments were performed in ventricles of SHR (12–13 weeks old) and age-matched normotensive Wistar–Kyoto rats (WKY). Results: Basal as well as isoproterenol (Iso)-stimulated force of contraction (FOC) was markedly decreased in isolated electrically driven papillary muscles of SHR. Iso (3 µmol/l, 10 min) increased FOC by 0.91±0.20 mN in SHR and by 3.88±0.52 mN in WKY, respectively. Ca2+-uptake by sarcoplasmic reticulum (SR) at low ionized Ca2+-concentration was increased in homogenates from SHR. This was not due to altered expression of phospholamban (PLB), SR-Ca2+-ATPase and calsequestrin. However, PLB-phosphorylation at threonine-17 (PLB-PT-17) and the activity of Ca2+/calmodulin dependent protein kinase (Ca2+/Cam-PK) was increased in SHR. In addition, we found an enhanced protein kinase A (PKA)-dependent phosphorylation of the inhibitory subunit of troponin (TnI). In contrast, there was no difference in the activity or expression (protein- and mRNA-level) of protein phosphatases type 1 or type 2A between SHR and WKY. Conclusions: It is suggested that increased Ca2+/Cam-PK-activity with resulting increase of PLB-PT-17 enhanced SR-Ca2+-uptake in SHR and might contribute to the pathophysiological changes in cardiac hypertrophy of SHR.
KEYWORDS Contractile function; Gene expression; Hypertrophy; Protein kinases; Protein phosphorylation; SR (function)
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Periasamy, P. Bhupathy, and G. J. Babu Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology Cardiovasc Res, January 15, 2008; 77(2): 265 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Mills, H. Kubo, D. M. Harris, R. M. Berretta, V. Piacentino III, and S. R. Houser Phosphorylation of phospholamban at threonine-17 reduces cardiac adrenergic contractile responsiveness in chronic pressure overload-induced hypertrophy Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H61 - H70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Sipido and D. Eisner Something old, something new: Changing views on the cellular mechanisms of heart failure Cardiovasc Res, November 1, 2005; 68(2): 167 - 174. [Full Text] [PDF]
|
|
|
|
|
|
T. Zhang and J. H. Brown Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure Cardiovasc Res, August 15, 2004; 63(3): 476 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P B Massion and J-L Balligand Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice J. Physiol., January 1, 2003; 546(1): 63 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Luss, W. Schmitz, and J. Neumann A proteasome inhibitor confers cardioprotection Cardiovasc Res, April 1, 2002; 54(1): 140 - 151. [Abstract] [Full Text] [PDF]
|
|